7 Best Stocks for the Next 30 Days

Get them in a free Special Report, and get more Zacks Insights in our free e-newsletter, Profit from the Pros. Every issue includes a fresh Zacks #1 Bull Stock of the Day.

Close This Panel X

Are you a new Zacks Member or a visitor to Zacks.com?

Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Stocks on the Move 05/17/2013

Company Name Symbol %Change
VIASAT INC VSAT
19.35%
OLD SECOND B OSBC
5.76%
GAMCO INVEST GBL
4.61%
CORNING INC GLW
4.47%
SYNCHRONOSS SNCR
4.23%

CNO Financial Group (CNO)

by Zacks Equity Research

November 02, 2012 | Comments : 0 Recommended this article: (0)
CNO

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

CNO Financial Group's (CNO) third quarter earnings surpassed the Zacks Consensus Estimate and the year-ago numbers on the back of continued favorable trends in annuity spreads, annuity persistency and improving benefit ratios, and better investment results in the corporate segment. Besides enhancing shareholder value, the company remains focused on investing in its core business.

The latest recapitalization plan should improve the capital structure and debt maturity profile. It is also expected to augment earnings per share and ROE. Improved credit ratings, strong investment portfolio and declining expenses are the other positives. Although underwriting and pricing remain primary concerns, increasing new business volume, along with cost containment measures are expected to support the bottom line in the long run.

We retain our Outperform recommendation. Our six-month target price of $11.00 equates to 14.5x our earnings estimate for 2012. Given the expected annual cash dividend of $0.08, this price target implies an expected total return of 15.4% over that period.

Email Print Share Rate Pos Rate Neg

Read/Post Comments (0) | Recommended this article (0)

Please login to Zacks.com or register to post a comment.

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.